Having trouble viewing this email? View the content as a web page.

HSE Biocides ebulletin

Issued: 9 November 2022

This ebulletin contains information on regulating biocides in Northern Ireland (NI). 

The EU Biocidal Products Regulation (EU BPR) operates independently from the GB Biocidal Products Regulation (GB BPR), which applies in Great Britain.

Separate ebulletins containing information specific to regulating biocides in Great Britain are issued as appropriate.

Upcoming EU active substance open invitation deadlines

Submit a notification by the deadline to keep active substances in the EU Review Programme

The European Chemicals Agency (ECHA) has published open invitations to provide an opportunity for a person, company or task force/consortium to notify an intention to take up or take over the role of participant in the EU Review Programme for the following active substance/product type combinations.

This affects Northern Ireland (NI). Anyone wishing to support one of the active substance/product type combinations listed below in the EU will need to submit a notification to ECHA by the following deadlines:

• ‘Poly(oxy-1,2-ethanediyl), .alpha.-[2-(didecylmethylammonio)ethyl]- .omega.- hydroxy-, propanoate (salt) (“Bardap 26”)’ other than ‘reaction mass of N,N-didecyl-N-(2-hydroxyethyl)-N-methylammonium propionate and N,N-didecyl-N-(2-(2-hydroxyethoxy)ethyl)-N-methylammonium propionate and N,N-didecyl-N-(2-(2-(2-hydroxyethoxy)ethoxy)ethyl)-N-methylammonium propionate’ (CAS 94667-33-1 EC n/a) in product types 2, 4 and 10
  4 October 2023

If a notification to take over the role of participant is not received, these active substance/product type combinations will be subject to an EU non-approval decision. Biocidal products containing active substances with EU non-approval decisions for the relevant product types will have to be removed from the NI market. HSE will provide separate updates on these where relevant.

If you are aware of any disproportionate negative effects that are likely to arise from the non-approval of any of the active substance/product type combinations listed above, please contact us.

EU active substance expiry dates postponed

Active substance expiry dates postponed whilst the renewal evaluation is completed in the EU

For reasons beyond the control of the applicants, the approvals of the active substance/product type combinations listed below were likely to expire before a decision could be taken on their renewal under the EU BPR.

To allow sufficient time for the renewal evaluation to be completed, a decision has been taken to postpone the expiry of the approvals until the following dates. This affects Northern Ireland (NI):

• Acrylaldehyde (Acrolein) (CAS 107-02-8 EC 203-453-4) in product type 12
  28 February 2025
  
  
• Spinosad as a mixture of 50-95 % spinosyn A and 5-50 % spinosyn D (Spinosad) (CAS 168316-95-8 EC 434-300-1) in product type 18 
  30 April 2025
  
  
• medetomidine (CAS 86347-14-0 EC n/a) in product type 21
  30 June 2025
  
  
• Reaction mass of N,N- Didecyl-N,N-dimethylammonium Carbonate and N,N-Didecyl-N,N-dimethylammonium Bicarbonate (DDACarbonate) (CAS 894406-76-9 EC 451-900-9) in product type 8  
  30 June 2025
  
  
• 3-iodo-2-propynylbutylcarbamate (IPBC) (CAS 55406-53-6 EC 259-627-5) in product type 8 
  31 July 2025
  
  
• 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol (Tebuconazole) (CAS 107534-96-3 EC 403-640-2) in product type 8 
  30 June 2026
  
  
• 3-phenoxybenzyl-2-(4-ethoxyphenyl)-2-methylpropylether (Etofenprox) (CAS 80844-07-1 EC 407-980-2) in product type 8
  31 October 2026
  
  
• Cyclohexylhydroxydiazene 1-oxide, potassium salt (K-HDO) (CAS 66603-10-9 EC n/a) in product type 8 
  31 December 2026

If you want to supply new biocidal products containing these active substances, you can still apply for EU BPR product authorisation.

New products (including new trade names) must not be supplied in NI until product authorisation is granted.

HSE will provide separate updates on the renewal decisions when relevant.